Skull base osteomyelitis secondary to malignant otitis externa.

Curr Opin Otolaryngol Head Neck Surg

Division of Otolaryngology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey, USA.

Published: October 2003

Purpose Of Review: Skull base osteomyelitis secondary to malignant otitis externa was first described in 1959. Since then, advances have been made in the diagnosis, treatment, and clinical outcomes of this condition.

Recent Findings: This review discusses the pathophysiology and microbiology of malignant otitis externa. The review highlights the sometimes subtle presenting symptoms and recent advances in imaging and their practical application to diagnosing and monitoring the disease. Therapy for malignant otitis externa has changed since this entity was first described; this article reviews the medical, surgical, and adjuvant therapies and the relevant controversies.

Summary: The review discusses the history, pathogenesis, diagnosis, and treatment of skull base osteomyelitis in the context of malignant otitis externa with particular emphasis on HIV, children, and other immunodeficient states.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00020840-200310000-00002DOI Listing

Publication Analysis

Top Keywords

malignant otitis
20
otitis externa
20
skull base
12
base osteomyelitis
12
osteomyelitis secondary
8
secondary malignant
8
diagnosis treatment
8
review discusses
8
malignant
5
otitis
5

Similar Publications

Preadmission systemic antibiotic treatment in necrotizing otitis externa (NOE).

Eur Arch Otorhinolaryngol

December 2024

Department of Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Tel Hashomer, Israel.

Purpose: Necrotizing otitis externa (NOE) is a serious life-threatening infection, with Pseudomonas (PA) aeruginosa being the primary causative agent. Over the last two decades the use of systemic anti-PA antibiotics expanded substantially and are now prescribed regularly by physicians. Meanwhile, studies indicate shifting trends in the incidence of the offending pathogen in NOE.

View Article and Find Full Text PDF

Objective: Malignant otitis externa (MOE) is typically managed with long-term broad-spectrum antibiotics. The impact of surgical intervention on clinical outcomes is not well described. This study aims to compare clinical outcomes of MOE patients managed with or without surgery.

View Article and Find Full Text PDF

DOCK8 deficiency is the most common cause of autosomal recessive hyper-IgE syndrome (AR-HIES). The clinical spectrum is wide resulting in combined immunodeficiency, atopy, autoimmunity, and malignancies. To study the clinical and molecular profile of 20 patients with DOCK8 deficiency.

View Article and Find Full Text PDF

Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study.

Radiother Oncol

January 2025

School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; School of Medicine, College of Medicine, National SunYat-Sen University, Kaohsiung, Taiwan; Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Electronic address:

Background: Data evaluating the impact of intensity-modulated proton therapy (IMPT) on survival among nasopharyngeal carcinoma (NPC) patients are limited. This study aims to elucidate the survival benefits and toxicity profiles of IMPT compared to modern photon therapy, volumetric-modulated arc therapy (VMAT), over an extended follow-up period.

Methods: We analyzed data from NPC patients recorded in the Chang Gung Research Database.

View Article and Find Full Text PDF

Ewing's Sarcoma is type of malignant round cell neoplasm, representing only 1-4% of all ES cases. Temporal bone ES is often confused with chronic otitis media as clinical picture is quite similar i.e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!